| Description |
Join leading regulatory and industry experts to discuss the compelling advantages, and help you navigate the complexities, of global drug development in the vibrant Latin American region, including the current status of the Pan American Network for Drug Regulatory Harmonization (PANDRH).
• Receive updates on global regulatory environments and how they impact the access of medicines and future research and development in the region
• Discussions will highlight the benefits, barriers, and direction of harmonization and regulatory trends across the development lifecycle
Sessions include:
• Current Status of Pan American Network for Drug Regulatory Harmonization (PANDRH): Overview and Working Group
• Good Regulatory Practice (GRP): Ensuring Quality Throughout the Regulatory Process
• Collaborative Efforts on Inspections
• Collaborative Efforts on Pharmacovigilance
• Global Clinical Development: Opportunities in Latin America
• Biotechnology Paradigm in Latin America
• Promoting Faster Access by Globalizing Regulatory Processes
• Much more!
Simultaneous English/Spanish Translation Available
Hear from Experts Representing:
AMEIFAC, Mexico; CENCEC, Cuba; INAME, Argentina;
Center for Drug Evaluation and Research, FDA, USA; PhRMA, USA; OCA Hospital / Monterrey International Research Center, Mexico; Health Canada; Boehringer Ingelheim Mexico; Centre for Medicines Research International, UK; Universidad San Martín de Porres, Peru; Instituto Nacional de Higiene Rafel Rangel. Venezuela; Office of the Commissioner, FDA, US; CECMED, Cuba; Parexel, Argentina; Covance Inc., Mexico; and many more!
Conference Information:
USA: Ellen Diegel, Program Manager
Phone: 215-442-6158, Fax: (215) 293-5965
Email: ellen.diegel@diahome.org
Registration and Hotel:
B.P. Servimed, S.A. De C.V.
Email: dia@servimed.com.mx
Register Online:
http://www.servimed.com.mx/DIA09/indexi.htm
|
|
